Induction of apoptosis in rat cardiocytes by A3 adenosine receptor activation and its suppression by isoproterenol

Experimental Cell Research

Volumn 257, Issue 1, 2000, Pages 111-126

  Shneyvays, V ^a   Jacobson, K A ^b   Li, A H ^b   Nawrath, H ^c   Zinman, T ^a   Isaac, A ^a   Shainberg, A ^a  

^a BAR ILAN UNIVERSITY   (Israel)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Adenosine receptors; Apoptosis; Image analysis; Immunohistochemistry; Isoproterenol; Light and electron microscopy

Indexed keywords

ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; BUCLADESINE; CALCIUM; CASPASE 3; CYCLIC AMP DEPENDENT PROTEIN KINASE; DNA; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE; PROTEIN BCL 2;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTRON MICROSCOPY; GENE; HEART MUSCLE CELL; IMAGE ANALYSIS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICROSCOPY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0034713235     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.4882     Document Type: Article

References (54)

1. 3 adenosine receptor. Proc. Natl. Acad. Sci. USA. 89:1992;7432-7436.
2. 2 receptor activation. Circ. Res. 81:1997;415-422.
3. 3 receptor activation in rats. Eur. J. Pharmacol. 298:1996;293-297.
4. Liang B. T., Jacobson K. A. A physiological role of the adenosine A3 receptor: Sustained cardioprotection. Proc. Natl. Acad. Sci. USA. 95:1998;6995-6999.
5. 3 receptors: Novel ligands and paradoxical effects. Trends Pharmacol. Sci. 19:1998;184-191.
6. 3 receptors in rat brain. Mol. Pharmacol. 48:1995;1038-1045.
7. 2+-ionophore-induced secretion in a rat mast cell line. J. Pharmacol. Exp. Ther. 276:1996;837-845.
8. Shneyvays V., Nawrath H., Jacobson K. A., Shainberg A. Induction of apoptosis in cardiac myocytes by an A3 adenosine receptor agonist. Exp. Cell Res. 243:1998;383-397.
9. Auchampach J. A., Bolli R. Adenosine receptor subtypes in the heart: therapeutic opportunities and challenges. Am. J. Physiol. 276:1999;H1113-H1116.
10. Kohno Y., Yoshitatsu S., Koshiba M., Kim H. O., Jacobson K. A. Induction of apoptosis in HL-60 human promyelocytic leukemia cells by adenosine A3 receptor agonists. Biochem. Biophys. Res. Commun. 219:1996;904-910.
11. 3 receptor - Pathophysiological significance and therapeutic implications for neurodegenerative disorders. Ann. N. Y. Acad. Sci. 825:1997;11-22.
12. Barbieri D., Abbracchio M. P., Salvioli S., Monti D., Cossarizza A., Ceruti S., Brambilla R., Cattabeni F., Jacobson K. A., Franceschi C. Apoptosis by 2-chloro-2′-deoxy-adenosine and 2-chloro-adenosine in human peripheral blood mononuclear cells. Neurochem. Int. 32:1998;493-504.
13. Li A. H., Moro S., Melman N., Ji X. D., Jacobson K. A. Structure-activity relationships and molecular modeling of 3,5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists. J. Med. Chem. 41:1998;3186-3201.
14. 2b receptors in cultured fetal chick heart cells: High- and low-affinity coupling to stimulation of myocyte contractility and cAMP accumulation. Circ. Res. 76:1995;242-251.
15. 2a receptor activation in rat heart. Am. J. Physiol. 276:1999;H341-H349.
16. Wu C. F., Bishopric N. H., Pratt R. E. Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. J. Biol. Chem. 272:1997;14860-14866.
17. Weinstein L., Brik H., Rotmench H. H., Shainberg A. Characterization of sarcoplasmic reticulum in skinned heart muscle cultures. J. Cell. Physiol. 148:1991;124-132.
18. Bereiter-Hahn J. Dimethylaminostyrylmethylpyridiniumiodine (DASPMI) as a fluorescent probe for mitochondria in situ. Biochim. Biophys. Acta. 423:1976;1-14.
19. Kuznetsov A. V., Mayboroda O., Kunz D., Winkler K., Schubert W., Kunz W. S. Functional imaging of mitochondria in saponin-permeabilized mice muscle fibers. J. Cell Biol. 140:1998;1091-1099.
20. Claycomb W. C., Moses R. L. Growth factor and TPA stimulate DNA synthesis and alter the morphology of cultured terminally differentiated adult rat cardiac muscle cells. Dev. Biol. 127:1988;257-265.
21. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3450.
22. Geng Y. J., Ishikawa Y., Vatner D. E., Wagner T. E., Bishop S. P., Vatner S. F., Homcy C. J. Apoptosis of cardiac myocytes in Gsalpha transgenic mice. Circ. Res. 84:1999;34-42.
23. Desjardins L. M., MacManus J. P. An adherent cell model to study different stages of apoptosis. Exp. Cell Res. 216:1995;380-387.
24. Wibo M., Bravo G., Godfraind T. Postnatal maturation of excitation-contraction coupling in rat ventricle in relation to the subcellular localization and surface density of 1,4-dihydropyridine and ryanodine receptors. Circ. Res. 68:1991;662-673.
25. Chow S. C., Kass G. E., Orrenius S. Purines and their roles in apoptosis. Neuropharmacology. 36:1997;1149-1156.
26. Wyllie A. H., Kerr J. F., Currie A. R. Cell death: The significance of apoptosis. Int. Rev. Cytol. 68:1980;251-306.
27. Kerr J. F., Gobe G. C., Winterford C. M., Harmon B. V. Anatomical methods in cell death. Methods Cell Biol. 46:1995;1-27.
28. Abbracchio M. P., Burnstock G. Purinergic signalling: Pathophysiological roles. Jpn. J. Pharmacol. 78:1998;113-145.
29. Kerr J. F. Shrinkage necrosis: A distinct mode of cellular death. J. Pathol. 105:1971;13-20.
30. Kerr J. F., Wyllie A. H., Currie A. R. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26:1972;239-257.
31. Gavrieli Y., Sherman Y., Ben Sasson S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:1992;493-501.
32. Bobryshev Y. V., Babaev V. R., Lord R. S., Watanabe T. Cell death in atheromatous plaque of the carotid artery occurs through necrosis rather than apoptosis. In Vivo. 11:1997;441-452.
33. Gold R., Schmied M., Giegerich G., Breitschopf H., Hartung H. P., Toyka K. V., Lassmann H. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab. Invest. 71:1994;219-225.
34. Migheli A., Attanasio A., Schiffer D. Ultrastructural detection of DNA strand breaks in apoptotic neural cells by in situ end-labelling techniques. J. Pathol. 176:1995;27-35.
35. Hegyi L., Hardwick S. J., Mitchinson M. J., Skepper J. N. The presence of apoptotic cells in human atherosclerotic lesions. Am. J. Pathol. 150:1997;371-373.
36. Saraste A., Voipio-Pulkki L. M., Parvinen M., Pulkki K. Apoptosis in the heart. N. Engl. J. Med. 336:1997;1025-1026.
37. Kanoh M., Takemura G., Misao J., Hayakawa Y., Aoyama T., Nishigaki K., Noda T., Fujiwara T., Fukuda K., Minatoguchi S., Fujiwara H. Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: Not apoptosis but DNA repair. Circulation. 99:1999;2757-2764.
38. Takemura G., Ohno M., Fujiwara H. Ischemic heart disease and apoptosis. Rinsho Byori. 45:1997;606-613.
39. Takemura G., Ohno M., Hayakawa Y., Misao J., Kanoh M., Ohno A., Uno Y., Minatoguchi S., Fujiwara T., Fujiwara H. Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction. Circ. Res. 82:1998;1130-1138.
40. James T. N. Normal and abnormal consequences of apoptosis in the human heart. Circulation. 90:1994;556-574.
41. 3 antagonists. Biochem. Biophys. Res. Commun. 232:1997;317-322.
42. 3 receptors. J. Clin. Invest. 98:1996;1773-1779.
43. 2B receptors. Hypertension. 31:1998;943-948.
44. 2B receptors. Hypertension. 31:1998;516-521.
45. Krajewski S., Krajewska M., Ellerby L. M., Welsh K., Xie Z., Deveraux Q. L., Salvesen G. S., Bredesen D. E., Rosenthal R. E., Fiskum G., Reed J. C. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc. Natl. Acad. Sci. USA. 96:1999;5752-5757.
46. Haldar S., Chintapalli J., Croce C. M. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res. 56:1996;1253-1255.
47. Kamata H., Hirata H. Redox regulation of cellular signalling. Cell Signal. 11:1999;1-14.
48. Pierzchalski P., Reiss K., Cheng W., Cirielli C., Kajstura J., Nitahara J. A., Rizk M., Capogrossi M. C., Anversa P. p53 induces myocyte apoptosis via the activation of the renin-angiotensin system. Exp. Cell Res. 234:1997;57-65.
49. 2+ response patterns in target cells attacked by human natural killer cells. J. Physiol. (London). 495:1996;319-329.
50. Wang L., Ma W., Markovich R., Chen J. W., Wang P. H. Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I. Circ. Res. 83:1998;516-522.
51. Green D. R., Reed J. C. Mitochondria and apoptosis. Science. 281:1998;1309-1312.
52. 2+ current in the early stages of cardiomyocyte development. Circ. Res. 84:1999;136-145.
53. Bishopric N. H., Kedes L. Adrenergic regulation of the skeletal alpha-actin gene promoter during myocardial cell hypertrophy. Proc. Natl. Acad. Sci. USA. 88:1991;2132-2136.
54. Bishopric N. H., Sato B., Webster K. A. Beta-adrenergic regulation of a myocardial actin gene via a cyclic AMP-independent pathway. J. Biol. Chem. 267:1992;20932-20936.